These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32824392)

  • 1. The Role of Primary Tumor Resection in Colorectal Cancer Patients with Asymptomatic, Synchronous, Unresectable Metastasis: A Multicenter Randomized Controlled Trial.
    Park EJ; Baek JH; Choi GS; Park WC; Yu CS; Kang SB; Min BS; Kim JH; Kim HR; Lee BH; Oh JH; Jeong SY; Jung M; Ahn JB; Baik SH
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: Study protocol for a randomized controlled trial.
    Kim CW; Baek JH; Choi GS; Yu CS; Kang SB; Park WC; Lee BH; Kim HR; Oh JH; Kim JH; Jeong SY; Ahn JB; Baik SH
    Trials; 2016 Jan; 17():34. PubMed ID: 26782254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group.
    van der Kruijssen DEW; Elias SG; van de Ven PM; van Rooijen KL; Lam-Boer J'; Mol L; Punt CJA; Sommeijer DW; Tanis PJ; Nielsen JD; Yilmaz MK; van Riel JMGH; Wasowiz-Kemps DK; Loosveld OJL; van der Schelling GP; de Groot JWB; van Westreenen HL; Jakobsen HL; Fromm AL; Hamberg P; Verseveld M; Jaensch C; Liposits GI; van Duijvendijk P; Oulad Hadj J; van der Hoeven JAB; Trajkovic M; de Wilt JHW; Koopman M;
    Ann Oncol; 2024 Sep; 35(9):769-779. PubMed ID: 38852675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis.
    Kim MS; Chung M; Ahn JB; Kim CW; Cho MS; Shin SJ; Baek SJ; Hur H; Min BS; Baik SH; Kim NK
    J Surg Oncol; 2014 Aug; 110(2):214-21. PubMed ID: 24668581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative chemotherapy prior to primary tumour resection for asymptomatic synchronous unresectable colorectal liver-limited metastases: The RECUT multicenter randomised controlled trial.
    Lin Q; Ding K; Zhao R; Wang H; Wei Y; Ren L; Ye Q; Cui Y; He G; Tang W; Feng Q; Zhu D; Chang W; Wang X; Liang L; Zhou G; Liang F; Ye F; Wang J; Fan J; Xu J
    Eur J Cancer; 2023 Sep; 191():112961. PubMed ID: 37473466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of primary tumor resection for asymptomatic colorectal cancer patients with unresectable metastases: a systematic review and meta-analysis.
    Li S; Ji L; Huang J; Wang Y; Liu P; Zhang W; Lou Z
    Int J Colorectal Dis; 2023 Aug; 38(1):214. PubMed ID: 37581775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Upfront Chemotherapy on the Effect of Primary Tumour Resection for Asymptomatic Synchronous Colorectal Cancer With Unresectable Metastases: A Propensity-Score-Matched Cohort Analysis.
    Huang L; Wei G; Chen N; Liu J; Wang Z; Yu Y; Qiu M
    Clin Med Insights Oncol; 2022; 16():11795549221085054. PubMed ID: 35355515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
    Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
    World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial.
    Kanemitsu Y; Shitara K; Mizusawa J; Hamaguchi T; Shida D; Komori K; Ikeda S; Ojima H; Ike H; Shiomi A; Watanabe J; Takii Y; Yamaguchi T; Katsumata K; Ito M; Okuda J; Hyakudomi R; Shimada Y; Katayama H; Fukuda H;
    J Clin Oncol; 2021 Apr; 39(10):1098-1107. PubMed ID: 33560877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of upfront primary tumor resection in asymptomatic patients with unresectable stage IV colorectal cancer: A systematic review and meta-analysis.
    Liang Z; Liu Z; Huang C; Chen X; Zhang Z; Xiang M; Hu W; Wang J; Feng X; Yao X
    Front Surg; 2022; 9():1047373. PubMed ID: 36684350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer.
    Shin JE; An HJ; Shim BY; Kim H; Park HS; Cho HM; Kye BH; Yoo RN; Moon JY; Kim SH; Lee J; Lee HC; Jung JH; Lee KM; Lee JM
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary tumor resection for asymptomatic colorectal cancer patients with synchronous unresectable metastases: a meta-analysis of randomized controlled trials and case-matched studies.
    Huang J; Zhou J; Zhang P; Wu Q; Wang Z
    Langenbecks Arch Surg; 2024 Aug; 409(1):242. PubMed ID: 39105876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GRECCAR 8: impact on survival of the primary tumor resection in rectal cancer with unresectable synchronous metastasis: a randomized multicentre study.
    Cotte E; Villeneuve L; Passot G; Boschetti G; Bin-Dorel S; Francois Y; Glehen O;
    BMC Cancer; 2015 Feb; 15():47. PubMed ID: 25849254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Primary Tumor Resection on Survival in Asymptomatic Colorectal Cancer Patients With Unresectable Metastases.
    Doah KY; Shin US; Jeon BH; Cho SS; Moon SM
    Ann Coloproctol; 2021 Apr; 37(2):94-100. PubMed ID: 33979907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials.
    Rahbari NN; Biondo S; Frago R; Feißt M; Kreisler E; Rossion I; Serrano M; Jäger D; Lehmann M; Sommer F; Dignass A; Bolling C; Vogel I; Bork U; Büchler MW; Folprecht G; Kieser M; Lordick F; Weitz J;
    J Clin Oncol; 2024 May; 42(13):1531-1541. PubMed ID: 38412408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of resection versus no resection of the primary tumor on survival in patients with colorectal cancer and synchronous unresectable metastases: protocol for a randomized multicenter study (CR4).
    Biondo S; Frago R; Kreisler E; Espin-Basany E;
    Int J Colorectal Dis; 2017 Jul; 32(7):1085-1090. PubMed ID: 28497402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases.
    Huang M; Yang Y; Li Q; Wang C; Liang L; Zhu X; Zhang W; Chen Z; Huang D; Li W; Zhang X; Zhao X; Qiu L; Geng Q; Yu N; Du W; Sun S; Sheng X; Li X; Guo W
    Front Oncol; 2022; 12():747124. PubMed ID: 35174078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of primary tumor resection in patients with stage IV colorectal cancer with unresectable metastases.
    Urvay S; Eren T; Civelek B; Kilickap S; Yetiysigit T; Ozaslan E
    J BUON; 2020; 25(2):939-944. PubMed ID: 32521889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial.
    van der Kruijssen DEW; Elias SG; Vink GR; van Rooijen KL; 't Lam-Boer J; Mol L; Punt CJA; de Wilt JHW; Koopman M;
    JAMA Surg; 2021 Dec; 156(12):1093-1101. PubMed ID: 34613339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review.
    de Mestier L; Manceau G; Neuzillet C; Bachet JB; Spano JP; Kianmanesh R; Vaillant JC; Bouché O; Hannoun L; Karoui M
    World J Gastrointest Oncol; 2014 Jun; 6(6):156-69. PubMed ID: 24936226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.